First Header Logo Second Header Logo

Connection

Haodong Xu to Carcinoma, Squamous Cell

This is a "connection" page, showing publications Haodong Xu has written about Carcinoma, Squamous Cell.
Connection Strength

1.181
  1. Choy B, Findeis-Hosey JJ, Li F, McMahon LA, Yang Q, Xu H. High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung. Int J Clin Exp Pathol. 2013; 6(11):2542-7.
    View in: PubMed
    Score: 0.400
  2. Findeis-Hosey JJ, Xu H. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer. Biotech Histochem. 2012 Jan; 87(1):24-9.
    View in: PubMed
    Score: 0.345
  3. Xu H, Lu DW, El-Mofty SK, Wang HL. Metachronous squamous cell carcinomas evolving from independent oropharyngeal and pulmonary squamous papillomas: association with human papillomavirus 11 and lack of aberrant p53, Rb, and p16 protein expression. Hum Pathol. 2004 Nov; 35(11):1419-22.
    View in: PubMed
    Score: 0.215
  4. Lewis JS, Tarabishy Y, Luo J, Mani H, Bishop JA, Leon ME, Prasad ML, Xu H, Di Palma S. Inter- and intra-observer variability in the classification of extracapsular extension in p16 positive oropharyngeal squamous cell carcinoma nodal metastases. Oral Oncol. 2015 Nov; 51(11):985-990.
    View in: PubMed
    Score: 0.114
  5. Ji C, Zhang B, Zhu W, Ling C, Hu X, Chen Y, Huang J, Guo L, Xu H. Evaluation of ยน8F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer. Int J Clin Exp Pathol. 2014; 7(11):8227-34.
    View in: PubMed
    Score: 0.107
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.